How to find, vet and defend an expert witness
In IP litigation, technical expertise can make or break a case. But in popular fields, finding an available and unconflicted expert witness has quietly become one of the biggest challenges for attorneys.
In complex litigation, finding the right expert can take as much energy as building the case itself. Structured expert qualification turns a procedural step into real risk management.
Since its creation in 2012 under the America Invents Act, the PTAB has become the go-to venue for patent validity disputes. Yet finding, screening, and managing experts there poses unique challenges.
A practical guide to evaluating expert sourcing partners — ask smarter questions, spot red flags, and avoid generic services before committing to your next search.
A playbook for IP, tech, and life sciences teams to scout and vet the right expert without risky gaps or wasted time, using smarter processes and litigation data.
A fast, practical checklist of seven risks seasoned litigators check upfront — so you can move faster, catch warnings early, and protect client trust.
Sourcing the right expert can be just as important as drafting the perfect argument, but the process often becomes a second job. Connect is an end-to-end workflow layer built for modern litigation.
Big Data and AI are revolutionizing how legal teams source expert witnesses, replacing slow, opaque referrals with data-driven precision and efficiency.
In PTAB and Section 337 ITC cases, finding the right expert fast is critical. Patexia Connect's data-driven platform removes the pain points of slow, manual expert sourcing.
Niche skill gaps, slow vetting, hidden conflicts, and cost overruns derail high-stakes litigation. See how Patexia Connect solves all four with AI-powered expert matching.
An analysis of the most litigated technologies in IPR and PGR proceedings from 2020 to 2024, and the expert profiles in highest demand for each top IPC code.
How Patexia Connect bridges legal teams and life sciences experts to navigate high-stakes IP litigation, from ANDA cases to biotech, pharma, and medical devices.